The specific chronological age at which a woman experiences the final cessation of menstrual periods, marking the permanent end of reproductive capacity due to the loss of ovarian follicular function. This timing is a significant clinical biomarker, as both early and late menopause are associated with distinct long-term health risks, including cardiovascular and skeletal changes. Understanding and potentially modulating the factors that influence this timing is a focus in female hormonal health and longevity. It is defined retrospectively after twelve consecutive months of amenorrhea.
Origin
The term is fundamental to reproductive endocrinology and gynecology, describing a major, irreversible transition in the female life cycle. Its etymology is from the Greek words men (month) and pausis (cessation). The clinical focus on “timing” reflects the epidemiological data linking the age of menopause onset to overall healthspan.
Mechanism
Menopause timing is fundamentally determined by the depletion rate of the ovarian follicular reserve, which is largely genetically predetermined but also influenced by environmental and lifestyle factors. As the reserve declines, the ovaries become refractory to gonadotropins (FSH and LH), leading to a drastic reduction in estrogen and progesterone production. This hormonal withdrawal drives the associated systemic and symptomatic changes.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.